Zynex said yesterday that it has uplisted its common shares onto the Nasdaq Capital Market.
The Englewood, Colo.-based company said that its shares have already been approved to be listed on the Nasdaq Capital Market and are expected to begin trading under its existing symbol, “ZYXI”, beginning February 12.
“We are excited to reach this important milestone for Zynex. We have made significant progress over the past several years and uplisting to Nasdaq will help us communicate our story to a broader audience. We are now better positioned to attract institutional investors, which will fundamentally enhance the value of our company,” founder & CEO Thomas Sandgaard, said in an SEC filing.
In February 2016, Zynex said it named Peak 10 Publishing and Summit Container Corp. veteran Michael Hartberger to be its new COO.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.